Cargando…
PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430288/ http://dx.doi.org/10.1097/01.HS9.0000974528.70124.b5 |
| _version_ | 1785090926923743232 |
|---|---|
| author | Tam, Constantine Shadman, Mazyar Sharman, Jeff Cull, Gavin Phillips, Tycel Trotman, Judith Cohen, Aileen Allewelt, Heather Crescenzo, Rocco Delarue, Richard Zhang, Heather Tariq, Bilal Sahasranaman, Sri Ou, Ying C Flinn, Ian W |
| author_facet | Tam, Constantine Shadman, Mazyar Sharman, Jeff Cull, Gavin Phillips, Tycel Trotman, Judith Cohen, Aileen Allewelt, Heather Crescenzo, Rocco Delarue, Richard Zhang, Heather Tariq, Bilal Sahasranaman, Sri Ou, Ying C Flinn, Ian W |
| author_sort | Tam, Constantine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430288 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104302882023-08-17 PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES Tam, Constantine Shadman, Mazyar Sharman, Jeff Cull, Gavin Phillips, Tycel Trotman, Judith Cohen, Aileen Allewelt, Heather Crescenzo, Rocco Delarue, Richard Zhang, Heather Tariq, Bilal Sahasranaman, Sri Ou, Ying C Flinn, Ian W Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430288/ http://dx.doi.org/10.1097/01.HS9.0000974528.70124.b5 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Tam, Constantine Shadman, Mazyar Sharman, Jeff Cull, Gavin Phillips, Tycel Trotman, Judith Cohen, Aileen Allewelt, Heather Crescenzo, Rocco Delarue, Richard Zhang, Heather Tariq, Bilal Sahasranaman, Sri Ou, Ying C Flinn, Ian W PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES |
| title | PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES |
| title_full | PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES |
| title_fullStr | PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES |
| title_full_unstemmed | PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES |
| title_short | PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES |
| title_sort | pb1926: efficacy and safety of once daily (qd) vs twice daily (bid) zanubrutinib for patients with various b-cell malignancies: a comparative summary of clinical data and exposure-response analyses |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430288/ http://dx.doi.org/10.1097/01.HS9.0000974528.70124.b5 |
| work_keys_str_mv | AT tamconstantine pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses AT shadmanmazyar pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses AT sharmanjeff pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses AT cullgavin pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses AT phillipstycel pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses AT trotmanjudith pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses AT cohenaileen pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses AT alleweltheather pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses AT crescenzorocco pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses AT delaruerichard pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses AT zhangheather pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses AT tariqbilal pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses AT sahasranamansri pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses AT ouyingc pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses AT flinnianw pb1926efficacyandsafetyofoncedailyqdvstwicedailybidzanubrutinibforpatientswithvariousbcellmalignanciesacomparativesummaryofclinicaldataandexposureresponseanalyses |